Stop antimicrobial resistance before treatment fails
Prescient identifies resistance risk before antibiotic failure occurs, enabling better prescribing decisions and reducing avoidable cost.
The Problem
Antimicrobial resistance is often detected after treatment failure.
- Empiric therapy misses resistance patterns
- Escalation happens late
- Costs escalate rapidly
Average impact
$35K per failed treatment episode
What Prescient Does Differently
Real-Time Resistance Risk Scoring
Prescient evaluates:
- Patient history
- Prior antibiotic exposure
- Microbiology patterns
- Local resistance trends
- Treatment trajectory signals
How It Works
At the Moment of Prescribing
When antibiotics are initiated:
- Patient risk profile is evaluated
- Resistance likelihood is scored
- Clinician receives real-time guidance
What Clinicians See
Actionable Signals — Not Retrospective Data
HIGH · AMR RISK
77M · Home Care
- Broad-spectrum antibiotics (Day 5)
- ESBL risk detected
- Escalation likely required
Composite Risk Score: 86
Clinical Impact
- Improved antibiotic selection
- Reduced treatment failure
- Better antimicrobial stewardship compliance
- Slower resistance development
Financial Impact
- Reduced cost per infection episode
- Lower LOS driven by failed treatments
- Avoided escalation therapies
Why This Is Different From Traditional Stewardship
Traditional Approach
- Retrospective review
- Lab-driven
- Delayed action
Prescient
- Real-time intervention
- Multi-signal predictive
- At prescribing moment
Integration
- Embedded into clinical workflow
- No change to prescribing systems required
- Delivered via alerts and dashboards
Pilot Approach
- Back-test against known resistance outcomes
- Evaluate avoided failures
- Measure cost impact
Make resistance visible before it happens
See how real-time scoring improves prescribing decisions and reduces cost.
